|
|
|
Volumn 23, Issue 3 SUPPL. 7, 1996, Pages 2-7
|
|
Ifosfamide in the treatment of lymphoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CARMUSTINE;
CHLORAMBUCIL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DEXAMETHASONE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
MESNA;
METHOTREXATE;
METHYLPREDNISOLONE;
MITOGUAZONE;
MITOXANTRONE;
PREDNISONE;
PROCARBAZINE;
TENIPOSIDE;
VINCRISTINE;
VINDESINE;
ADULT;
AGED;
ARTICLE;
B CELL LYMPHOMA;
BONE MARROW TRANSPLANTATION;
BURKITT LYMPHOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG INDUCED DISEASE;
DRUG MEGADOSE;
FOLLICULAR LYMPHOMA;
HODGKIN DISEASE;
HUMAN;
LYMPHOMA;
MAJOR CLINICAL STUDY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RELAPSE;
T CELL LYMPHOMA;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
HUMANS;
IFOSFAMIDE;
LYMPHOMA, NON-HODGKIN;
PREDNISONE;
SALVAGE THERAPY;
SURVIVAL RATE;
VINCRISTINE;
|
|
EID: 0029737964
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|
